Sun Pharmaceutical Industries Ltd

Merck & Co Inc said on Tuesday it had partnered with five Indian generic drugmakers, including Cipla Ltd and Sun Pharmaceutical Industries Ltd, to expand production and access to its experimental COVID-19 drug.

The S&P BSE Sensex on Friday were 19.41 points down and closed at 35,443.67. The National Stock Exchange (NSE) benchmark index Nifty50 settled at 10,767.65. Stock markets edged lower today after two straight sessions of gains. Markets witnessed a volatile trading during the day. Stock markets largely ended flat as losses in both indexes on account...

Sun Pharmaceutical Industries Ltd and Dr. Reddy's Laboratories Ltd, which gained in the last three sessions, fell 1.65 percent and 1.94 percent, respectively.

Sun Pharmaceutical Industries Ltd climbed more than 2.4 percent, helping the Nifty Pharma Index gain as much as 2.2 percent.

Healthcare stocks were the biggest drag on the index, after shares of Sun Pharmaceutical Industries Ltd fell as much as 13.2 percent to a near four-year low.

The lawsuit, filed in the US District Court for the District of Connecticut by 20 US states, also named Heritage Pharmaceuticals Inc, a company owned by Emcure Pharma Ltd, as a "ring leader" of the price manipulation.

Sun Pharmaceutical Industries Ltd, India's largest drugmaker, reported a quarterly profit that beat analysts' estimates, helped by its exclusive launch of the first generic version of leukaemia drug Gleevec in the United States.

Drug major Sun Pharmaceutical Industries Ltd on Monday announced the launch of ready-to-administer cancer drug Gemcitabine InfuSMART in Europe.

Sun Pharmaceutical Industries Ltd reported a near-doubling in fourth-quarter profit, although that missed analysts' estimates as weakness in emerging markets outweighed higher sales in India and the United States.

The US Department of Justice (DoJ) has subpoenaed India's largest drug maker Sun Pharmaceutical Industries Ltd seeking information about the pricing and marketing of the generic drugs it sells in the United States, the company said on Saturday.

Shares in India's largest drugmaker, Sun Pharmaceutical Industries Ltd, skidded more than 7 percent on Monday after U.S. regulators warned of standards violations at a key plant in the latest blow to India's generic drug industry.

India's largest drugmaker Sun Pharmaceutical Industries Ltd said it had received a warning letter from the US Food and Drug Administration for violating manufacturing standards at its Halol plant in western India.

Shares of Strides Arcolab surged nearly 4 per cent to Rs 1,191 at its day's high after the Bangalore-based pharma company reached a deal with Sun Pharmaceutical Industries Ltd to buy two marketing divisions of erstwhile Ranbaxy Laboratories.

Sun Pharmaceutical Industries $455 million in a joint venture in Mauritius, Biocon Ltd a total of $440.04 million in two separate tranches in a wholly owned unit in UAE and a joint venture in Malaysia.

Sun Pharmaceutical Industries Ltd, India's largest drugmaker by sales, said it is looking to divest a manufacturing plant in Ireland as it tries to control costs that have spiralled since it bought Ranbaxy Laboratories Ltd.

Merck & Co Inc said on Tuesday it had partnered with five Indian generic drugmakers, including Cipla Ltd and Sun Pharmaceutical Industries Ltd, to expand production and access to its experimental COVID-19 drug.

The S&P BSE Sensex on Friday were 19.41 points down and closed at 35,443.67. The National Stock Exchange (NSE) benchmark index Nifty50 settled at 10,767.65. Stock markets edged lower today after two straight sessions of gains. Markets witnessed a volatile trading during the day. Stock markets largely ended flat as losses in both indexes on account...

Sun Pharmaceutical Industries Ltd and Dr. Reddy's Laboratories Ltd, which gained in the last three sessions, fell 1.65 percent and 1.94 percent, respectively.

Sun Pharmaceutical Industries Ltd climbed more than 2.4 percent, helping the Nifty Pharma Index gain as much as 2.2 percent.

Healthcare stocks were the biggest drag on the index, after shares of Sun Pharmaceutical Industries Ltd fell as much as 13.2 percent to a near four-year low.

The lawsuit, filed in the US District Court for the District of Connecticut by 20 US states, also named Heritage Pharmaceuticals Inc, a company owned by Emcure Pharma Ltd, as a "ring leader" of the price manipulation.

Sun Pharmaceutical Industries Ltd, India's largest drugmaker, reported a quarterly profit that beat analysts' estimates, helped by its exclusive launch of the first generic version of leukaemia drug Gleevec in the United States.

Drug major Sun Pharmaceutical Industries Ltd on Monday announced the launch of ready-to-administer cancer drug Gemcitabine InfuSMART in Europe.

Sun Pharmaceutical Industries Ltd reported a near-doubling in fourth-quarter profit, although that missed analysts' estimates as weakness in emerging markets outweighed higher sales in India and the United States.

The US Department of Justice (DoJ) has subpoenaed India's largest drug maker Sun Pharmaceutical Industries Ltd seeking information about the pricing and marketing of the generic drugs it sells in the United States, the company said on Saturday.

Shares in India's largest drugmaker, Sun Pharmaceutical Industries Ltd, skidded more than 7 percent on Monday after U.S. regulators warned of standards violations at a key plant in the latest blow to India's generic drug industry.

India's largest drugmaker Sun Pharmaceutical Industries Ltd said it had received a warning letter from the US Food and Drug Administration for violating manufacturing standards at its Halol plant in western India.

Shares of Strides Arcolab surged nearly 4 per cent to Rs 1,191 at its day's high after the Bangalore-based pharma company reached a deal with Sun Pharmaceutical Industries Ltd to buy two marketing divisions of erstwhile Ranbaxy Laboratories.

Sun Pharmaceutical Industries $455 million in a joint venture in Mauritius, Biocon Ltd a total of $440.04 million in two separate tranches in a wholly owned unit in UAE and a joint venture in Malaysia.

Sun Pharmaceutical Industries Ltd, India's largest drugmaker by sales, said it is looking to divest a manufacturing plant in Ireland as it tries to control costs that have spiralled since it bought Ranbaxy Laboratories Ltd.